Weight-loss drugs such as semaglutides or tirzepatides may raise patients’ risk of nonarteritic anterior ischemic optic ...
The five-year trial saw patients who received a single injection of Lumevoq sustaining clinical recovery in a rare condition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results